173 related articles for article (PubMed ID: 3512457)
21. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
22. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model.
Shin YT; Adams DH; Wyner LR; Akalin E; Sayegh MH; Karnovsky MJ
Transplantation; 1995 Jun; 59(12):1647-53. PubMed ID: 7604433
[TBL] [Abstract][Full Text] [Related]
23. The effect of cyclosporin on major histocompatibility complex-linked resistance to murine cytomegalovirus.
Lawson CM; Hodgkin PD; Shellam GR
J Gen Virol; 1989 May; 70 ( Pt 5)():1253-9. PubMed ID: 2543779
[TBL] [Abstract][Full Text] [Related]
24. Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow.
Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP
Transplantation; 2002 Aug; 74(4):477-84. PubMed ID: 12352905
[TBL] [Abstract][Full Text] [Related]
25. DNA associated with the cell membrane is involved in the inhibition of the skin rejection response induced by infusions of photodamaged alloreactive cells that mediate rejection of skin allograft.
Perez MI; Yamane Y; John L; Gasparro FP; Edelson RL
Photochem Photobiol; 1992 Jun; 55(6):839-49. PubMed ID: 1409891
[TBL] [Abstract][Full Text] [Related]
26. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
Goss JA; Nakafusa Y; Flye MW
Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
[TBL] [Abstract][Full Text] [Related]
27. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
28. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment.
Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M
Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867
[TBL] [Abstract][Full Text] [Related]
29. The effect of donor-specific transfusion and cyclosporin A on small bowel transplantation in the rat.
Santiago SF; Fukuzawa M; Azuma T; Nezu R; Imura K; Takagi Y; Okada A
Surg Today; 1994; 24(5):429-34. PubMed ID: 8054814
[TBL] [Abstract][Full Text] [Related]
30. Intrathymic injection of donor alloantigens induces specific tolerance to cardiac allografts.
Goss JA; Nakafusa Y; Yu S; Flye MW
Transplantation; 1993 Jul; 56(1):166-73. PubMed ID: 8333039
[TBL] [Abstract][Full Text] [Related]
31. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. II. Effects of anti-Ia immunotherapy on host T cell responses to graft alloantigens.
Williams IR; Perry LL
J Immunol; 1985 May; 134(5):2942-7. PubMed ID: 3156920
[TBL] [Abstract][Full Text] [Related]
32. Prolongation of skin allograft survival by combined feeding of donor spleen cells and cyclosporine in mice.
Lu X; Zhou L; Chen S
Transplant Proc; 2004 Oct; 36(8):2429-31. PubMed ID: 15561269
[TBL] [Abstract][Full Text] [Related]
33. Importance of natural killer cells in the rejection of hamster skin xenografts.
Gourlay WA; Chambers WH; Monaco AP; Maki T
Transplantation; 1998 Mar; 65(5):727-34. PubMed ID: 9521210
[TBL] [Abstract][Full Text] [Related]
34. T cell-derived factor alone or in combination with immunosuppressive drugs augments prolongation of allogeneic skin graft survival in mice receiving donor-specific transfusion.
Gorczynski RM; Boulanger M; Lau C
J Immunol; 1987 May; 138(10):3197-202. PubMed ID: 2952712
[TBL] [Abstract][Full Text] [Related]
35. Prolongation of small bowel allografts after intrathymic injection of donor alloantigen and ALS.
Goss JA; Nakafusa Y; Flye MW
J Surg Res; 1993 May; 54(5):494-8. PubMed ID: 8361174
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of cyclosporine-induced suppressor cells in murine delayed-type hypersensitivity responses.
Mirisklavos A; Mottram PL; Dumble LJ; Clunie GJ
Int Arch Allergy Appl Immunol; 1986; 79(2):215-9. PubMed ID: 2935501
[TBL] [Abstract][Full Text] [Related]
37. Participation of the liver in generation of a vigorous anti-donor response after inoculation of donor spleen cells.
He L; Gotoh M; Dono K; Nagano H; Ota H; Ohta Y; Okuyama M; Takeda Y; Shimizu J; Grochowiecki T; Sakon M; Monden M
Transplantation; 1999 Oct; 68(7):950-7. PubMed ID: 10532533
[TBL] [Abstract][Full Text] [Related]
38. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
[TBL] [Abstract][Full Text] [Related]
39. The effect of timing of skin grafts on subsequent survival in ALS-treated, marrow-infused mice.
Wood ML; Monaco AP
Transplantation; 1977 Jan; 23(1):78-86. PubMed ID: 65036
[TBL] [Abstract][Full Text] [Related]
40. Allograft rejection and immune responses against allogeneic antigens in neonatally thymectomized mice.
Nomoto K; Mayumi H; Himeno K; Watanabe Y; Mitani M; Tokuda N
Transplantation; 1986 Feb; 41(2):209-13. PubMed ID: 3511583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
